Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles

Biomaterials

Volumn 24, Issue 13, 2003, Pages 2395-2404

  Hu, Yong ^a   Jiang, Xiqun ^a   Ding, Yin ^a   Zhang, Leyang ^a   Yang, Changzheng ^a   Zhang, Junfeng ^a   Chen, Jiangning ^a   Yang, Yonghua ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

L Lactide; Nanoparticles; Nimodipine; Poly(ethylene glycol); Caprolactone

Indexed keywords

CRITICAL MICELLE CONCENTRATION; HYDROPHOBICITY; LIGHT SCATTERING; MOLECULAR WEIGHT; NANOSTRUCTURED MATERIALS; POLYETHYLENE OXIDES; RING OPENING POLYMERIZATION; SYNTHESIS (CHEMICAL);

DRUG RELEASE BEHAVIOR;

BLOCK COPOLYMERS;

AMPHOPHILE; COPOLYMER; MACROGOL 10000; MACROGOL 2000; MACROGOL 6000; NANOPARTICLE; NIMODIPINE; POLYCAPROLACTONE POLYETHYLENE OXIDE POLYLACTIDE COPOLYMER; UNCLASSIFIED DRUG;

ARTICLE; DRUG RELEASE; DRUG SYNTHESIS; HYDROPHOBICITY; LIGHT SCATTERING; MOLECULAR WEIGHT; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; RING OPENING METATHESIS POLYMERIZATION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0037409984     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00021-8     Document Type: Article

References (26)

1. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 70:2001;1-20.
2. Petrak K. Pharmaceutical particulate carriers. Rolland A. Therapeutic application. 1993;275-297 Marcel Dekker Inc, New York.
3. Grislain L., Couvreur P., Lenaerts V., Roland M., Deprezdecampeneere D., Speiser P. Pharmacokinetics and distribution of a biodegradable drug-carrier. Int J Pharm. 15:1983;335-345.
4. Yong H., Xiqun J., Yin D., Haixiong G., Yuyan Y., Changzheng Y. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials. 23:2002;3193.
5. Mosqueira V.C.F., Legrand P., Morgat J-.L., Vert M., Mysiakine E., Gref R., Devissaguet J-.P., Barratt G. Biodistribution of long-circulating PEG-grafted Nanocapsules in mice. effects of PEG chain length and density Pharma Res. 18:2001;1411-1419.
6. Haixiong G., Yong H., Xiqun J., Daming C.H., Yuyan Y., Hong B., Changzheng Y. Preparation, characterization and drug release behaviors of drug nimodipine-loaded poly(ε-caprolactone)-poly (ethylene oxide)-poly(ε-caprolactone) amphiphilic triblock copolymer micelles. J Pharma Sci. 91:2002;1463-1473.
7. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263(18):1994;1600-1603.
8. Herold D.A., Keil K., Bruns D.E. Oxidation of polyethylene glycol by alcohol dehydrogenase. Biochem Pharmacol. 38:1989;73-76.
9. Richter A.W., Akerblom E. Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol-modified proteins. Int Arch Allergy Appl Immunol. 70:1983;124-131.
10. Tuzar Z., Kratochvil P. Block and graft copolymer micelles in solution. Adv Colloid Interface Sci. 6:1976;201-232.
11. Tobỳo M., Gref R., Sanchez A., Langer R., Alonso M.J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res. 15:1998;270-275.
12. Govender T., Riley T., Ehtezazi T., Garnett M.C., Stolink S., Illum L., Davis S.S. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharma. 199:2000;95-110.
13. Jeong Y-.I., Cheon J-.B., Kim S-.H., Nah J-.W., Lee Y-.M., Sung Y-.K., Akaike T., Cho C-.S. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release. 51:1998;169-178.
14. Kim S.Y., Shin I.G., Lee Y.M., Cho C.S. Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin II. Micelle formation and drug release behaviours. J Control Release. 51:1998;13-22.
15. Huyghens L.P., Rosseel M.T., Calle P.A., Buylaert W.A. Influence of cardiopulmonary resuscitation on plasma concentration of nimodipine in the dog. J Pharm Pharmacol. 39:1987;991-996.
16. Dairui C., Hongli C., Jianzhong B., Shenguo W. Morphology and biodegradation of microspheres of polyester-polyether block copolymer based on polycaprolactone/polylactide/poly(ethylene oxide). Polym Int. 49:2000;269-276.
17. Wilhelm M., Zhao C., Wang Y., Xu R., Winnik M.A., Mura J.L., Riess G., Croucher M.D. Poly(styrene-ethylene oxide) block copolymer micelle formation in water. a fluorescence probe study Macromolecules. 24:1991;1033-1040.
18. Kwon G.S., Naito M., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Physical entrapment of adriamycin in AB block copolymer micelles. Pharm Res. 11:1995;970-974.
19. Dong D.C., Winnik M.A. The pyrene scale of solvent polarities. Can J Chem. 62:1984;2560-2565.
20. Kalyanasundaram K., Thoms J.K. Enviromental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems. J Am Chem Soc. 99:1977;2039-2044.
21. Zhao C., Wang Y., Winnik M.A., Riess G., Croucher M.D. Fluorescence probe technique used to study micelle formation in water-soluble block co-polymer. Langmuir. 6:1990;514-516.
22. Shin I.G., Kim S.Y., Lee Y.M., Cho C.S., Sung Y.K. Methoxy poly9ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J Controlled Release. 51:1998;1-11.
23. Xu R.L., Winnik M.A., Hallett F.R., Gerard Riess, Croucher M.D. Light-scattering study of the association behavior styrene-ethylene oxide block copolymers in aqueous solution. Macromolecules. 24:1991;87-93.
24. Riley T., Govender T., Stolnik S., Xiong C.D., Garnett M.C., Illum L., Davis S.S. Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles. Colloids surface B: Biointerface. 16:1999;147-159.
25. Haixiong G., Yong H., Shicheng Y., Xiqun J., Changzheng Y. Preparation, characterization, and drug release behaviours of drug-loaded ε-caprolactone/L-lactide copolymer nanoparticles. J Appl Polym Sci. 75:2000;874-882.
26. Zuleger S., Lippold B.C. Polymer particle erosion controlling drug release. I Factors influence drug release and characterization of the release mechanism. Int J Pharma. 217:2001;139-152.